Conduction delays after transcatheter aortic valve implantation with balloon-expandable prosthesis and high implantation technique.
Calcium volume
Electrophysiological study
Permanent pacemaker implantation predictors
Transcatheter aortic valve implantation
Journal
Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
18
05
2021
accepted:
28
07
2021
pubmed:
16
9
2021
medline:
7
4
2022
entrez:
15
9
2021
Statut:
ppublish
Résumé
Performing transcatheter aortic valve implantation with high implantation technique, i.e. with an aorto-ventricular ratio > 60/40, reduces the need of permanent pacemaker implantation. Valve calcification and prosthesis oversizing are predictors of permanent pacemaker implantation, but there are no available data on their role when transcatheter aortic valve implantation is performed with an aorto-ventricular ratio > 60/40. The aim of this study was to evaluate the effect of leaflets/annulus calcification and prosthesis oversizing on the incidence of permanent pacemaker implantation after transcatheter aortic valve implantation with a high implantation technique. Transcatheter aortic valve implantation was performed in 48 patients implanting a balloon-expandable transcatheter heart valve with an aorto-ventricular ratio > 60/40. Calcium burden was assessed by preprocedural multidetector computed tomography. An invasive electrophysiological study was performed before and after transcatheter aortic valve implantation. Five patients (10.4%) needed permanent pacemaker implantation. At univariate analysis, baseline right bundle branch block and postprocedural PR, QRS and His-ventricular interval elongation significantly predicted permanent pacemaker implantation (p < 0.05). Receiver-operating characteristic curve analysis showed a correlation between transcatheter heart valve oversizing and permanent pacemaker implantation need, with the best cut-off being 17% (AUC = 0.72, p = 0.033). Linear regression analysis demonstrated that QRS complex elongation was related to total, left and non-coronary leaflet calcification (p < 0.05). This study demonstrates that, when transcatheter aortic valve implantation is performed using a balloon-expandable transcatheter heart valve deployed with an aorto-ventricular ratio > 60/40, the presence of leaflets/annulus calcification or the need to oversize the prosthesis correlate with the occurrence of pathological cardiac conduction delays.
Identifiants
pubmed: 34524496
doi: 10.1007/s00380-021-01913-z
pii: 10.1007/s00380-021-01913-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-346Subventions
Organisme : Edwards Lifesciences
ID : I15-220
Informations de copyright
© 2021. Springer Japan KK, part of Springer Nature.
Références
Leon MB, Smith CR, Mack M, Craig Miller D, Moses JW, Svensson LG, Murat Tuzcu E, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
doi: 10.1056/NEJMoa1008232
Smith CR, Leon MB, Mack MJ, Craig Miller D, Moses JW, Svensson LG, Murat Tuzcu E, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
doi: 10.1056/NEJMoa1103510
Walther T, Hamm CW, Schuler G, Berkowitsch A, Kötting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck K-H, Mohr FW, Möllmann H, GARY Executive Board (2015) Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol 65:2173–2180
doi: 10.1016/j.jacc.2015.03.034
Mack M, Leon M, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR, PARTNER 3 Investigators (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705
doi: 10.1056/NEJMoa1814052
De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H (2016) Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv 9:805–813
doi: 10.1016/j.jcin.2015.12.023
Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C (2016) Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 9:244–254
doi: 10.1016/j.jcin.2015.09.036
Kodali S, Thourani VH, White J, Malaisrie SC, Lim S, Greason KL, Williams M, Guerrero M, Eisenhauer AC, Kapadia S, Kereiakes DJ, Herrmann HC, Babaliaros V, Szeto WY, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Blanke P, Whisenant BK, Suri RM, Makkar RR, Ayele GM, Svensson LG, Webb JG, Mack MJ, Smith CR, Leon MB (2016) Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 37(28):2252–2262
doi: 10.1093/eurheartj/ehw112
Zhang ZM, Rautaharju PM, Soliman EZ, Manson JE, Cain ME, Martin LW, Bavry AA, Mehta L, Vitolins M, Prineas RJ (2012) Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women’s Health Initiative [WHI]). Am J Cardiol 110:1489–1495
doi: 10.1016/j.amjcard.2012.06.060
Zannad F, Huvelle E, Dickstein K, van Veldhuisen DJ, Stellbrink C, Køber L, Cazeau S, Ritter P, Maggioni AP, Ferrari R, Lechat P (2007) Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail 9:7–14
doi: 10.1016/j.ejheart.2006.04.011
Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, Rodés-Cabau J (2017) Conduction disturbances after transcatheter aortic valve replacement, current status and future perspectives. Circulation 136:1049–1069
doi: 10.1161/CIRCULATIONAHA.117.028352
Siontis GC, Jüni P, Pilgrim T, Stortecky S, Büllesfeld L, Meier B, Wenaweser P, Windecker S (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64:129–140
doi: 10.1016/j.jacc.2014.04.033
Latsios G, Gerckens U, Buellesfeld L, Mueller R, John D, Yuecel S, Syring J, Sauren B, Grube E (2010) “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 76:431–439
doi: 10.1002/ccd.22563
Kiani S, Kamioka N, Black GB, Louis Roy Lu M, Lisko JC, Rao B, Mengistu A, Gleason PT, Stewart JP, Caughron H, Dong A, Patel H, Grubb KJ, Greenbaum AB, Devireddy CM, Guyton RA, Leshnower B, Merchant FM, El-Chami M, Westerman SB, Lloyd MS, Babaliaros VC, Hoskins MH (2019) Development of a risk score to predict new pacemaker implantation after transcatheter aortic valve replacement. JACC Cardiovasc Interv 12:2133–2142
doi: 10.1016/j.jcin.2019.07.015
Tarantini G, Mojoli M, Purita P, Napodano M, D’Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S (2015) Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention 11:343–350
doi: 10.4244/EIJY14M11_06
Iacovelli F, Pignatelli A, Giugliano G, Stabile E, Cicala M, Salemme L, Cioppa A, Popusoi G, Pucciarelli A, Verdoliva S, Bortone AS, Losi M-A, Coscioni E, Esposito G, Tesorio T (2018) Prosthesis depth and conduction disturbances after last generation balloon-expandable transcatheter aortic valve implantation. Europace 20:116–123
pubmed: 28339584
Ramanathan PK, Nazir S, Elzanaty AM, Nesheiwat Z, Mahmood M, Rachwal W, Riordan C, Letcher J, Yenrick K, Boonie E, Moront MG, Redfern RE, Crescenzo D (2020) Novel method for implantation of balloon expandable transcatheter aortic valve replacement to reduce pacemaker rate—line of lucency method. Struct Heart 4(5):427–432
doi: 10.1080/24748706.2020.1813355
Rogers T, Koifman E, Patel N, Gai J, Torguson R, Corso P, Waksman R (2017) Society of Thoracic Surgeons score variance results in risk reclassification of patients undergoing transcatheter aortic valve replacement. JAMA Cardiol 2:455–456
doi: 10.1001/jamacardio.2016.4132
Barbanti M, Yang TH, Rodés Cabau J, Tamburino C, Wood DA, Jilaihawi H, Blanke P, Makkar RR, Latib A, Colombo A, Tarantini G, Raju R, Binder RK, Nguyen G, Freeman M, Ribeiro HB, Kapadia S, Min J, Feuchtner G, Gurtvich R, Alqoofi F, Pelletier M, Ussia GP, Napodano M, Sandoli de Brito F Jr, Kodali S, Norgaard BL, Hansson NC, Pache G, Canovas SJ, Zhang H, Leon MB, Webb JG, Leipsic J (2013) Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 128:244–253
doi: 10.1161/CIRCULATIONAHA.113.002947
Zhu D, Chen W, Peng L, Guo Y (2015) Valve sizing for pure aortic regurgitation during transcatheter aortic valve replacement: deformation dynamic of the aortic annulus in different valve pathology may be different. JACC Cardiovasc Interv 8:372–373
doi: 10.1016/j.jcin.2014.11.011
Angelillis M, Costa G, De Backer O, Mochia V, Christou A, Giannini C, Spontoni P, De Carlo M, Søndergaard L, Miccoli M, Petronio AS (2021) Threshold for calcium volume evaluation in patients with aortic valve stenosis: correlation with Agatston score. J Cardiovasc Med 22:496–502
doi: 10.2459/JCM.0000000000001145
Jilaihawi H, Makkar RR, Kashif M, Okuyama K, Chakravarty T, Shiota T, Friede G, Nakamura M, Doctor N, Rafique A, Shibayama K, Mihara H, Trento A, Cheng W, Friedman J, Berman D, Fontana GP (2014) A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 15:1324–1332
doi: 10.1093/ehjci/jeu162
Nashef SAM, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, Wyse RKH, Bruce Ferguson T, EurpSCORE Project Group (2002) Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 22:101–105
doi: 10.1016/S1010-7940(02)00208-7
Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es G-A, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB, Valve Academic Research Consortium (VARC)-2 (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60
doi: 10.1093/ejcts/ezs533
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A, Cleland J, Deharo J-C, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118
doi: 10.1093/europace/eut206
Moreno R, Dobarro D, López de Sá E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jiménez-Valero S, Lopez-Sendon J-L (2009) Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 120:e29–e30
doi: 10.1161/CIRCULATIONAHA.109.849281
Eksik A, Gul M, Uyarel H, Surgit O, Yildirim A, Uslu N, Aksu H, Turen S, Uzun F, Satılmısoglu H, Erol MK, Bakir I (2013) Electrophysiological evaluation of atrioventricular conduction disturbances in transcatheter aortic valve implantation with Edwards Sapien prosthesis. J Invasive Cardiol 25:305–309
pubmed: 23735359
Rivard L, Schram G, Asgar A, Khairy P, Andrade JG, Bonan R, Dubuc M, Guerra PG, Ibrahim R, Macle L, Roy D, Talajic M, Dyrda K, Shohoudi A, le Polain de Waroux J-B, Thibault B (2015) Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement. Heart Rhythm 12:321–329
doi: 10.1016/j.hrthm.2014.10.023
Fujita B, Kütting M, Seiffert M, Scholtz S, Egron S, Prashovikj E, Börgermann J, Schäfer T, Scholtz W, Preuss R, Gummert J, Steinseifer U, Ensminger SM (2016) Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 17:1385–1393
doi: 10.1093/ehjci/jev343
Staubach S, Franke J, Gerckens U, Schuler G, Zahn R, Eggebrecht H, Hambrecht R, Sack S, Richardt G, Horack M, Senges J, Steinberg DH, Ledwoch J, Fichtlscherer S, Doss M, Wunderlich N, Sievert H, Investigators G-R (2013) Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv 81:348–355
doi: 10.1002/ccd.24332